CenTrial Logo

Two Treatment Options for Sleep Disordered Breathing in Children


Clinical trial helps children with sleep-disordered breathing

Sleep-Disordered Breathing (SD
B) affects at least 12% of otherwise healthy children and is associated with significant morbidity. Currently, the American Academy of Pediatrics (AAP) recommends referral to a specialist for children with significant SDB symptoms.

Treatment options to date have included adenotonsillectomy, nasal steroids, and nasal dilator strips.  A new study, led by a team of researchers from the Department of Pediatrics at the University of Melbourne, Australia, set out to determine whether intranasal mometasone furoate is more effective than intranasal saline for improving symptoms and quality of life in children with SDB.

Breathing Easier

The team conducted a double-blind, randomized clinical trial of 276 children with SDB. The participants were randomly assigned to receive either mometasone furoate or sodium chloride (saline) intranasally, one spray per nostril daily, in identical bottles.  The primary outcome was the resolution of significant SDB symptoms (ie, reduction to a level no longer requiring referral to a specialist as per the AAP guidelines) at 6 weeks, measured by parental report of symptoms using the SDB Score.

The results of the trial showed that resolution of significant SDB symptoms occurred in 44% of participants in the mometasone group and 41% of participants in the saline group. This suggests that there was no difference in treatment effect between intranasal mometasone and saline for the management of SDB symptoms. The main adverse effects reported were epistaxis (nosebleeds) and nasal itch/irritation.

Are you interested in clinical trials near you?

You can receive free notification of a trial for this, or any other condition, by completing a short confidential health profile.
Find a clinical trial near me
The results of this trial suggest that almost one-half of children with SDB could be initially managed in the primary care setting, without referral to specialist services, as is currently recommended. Intranasal saline or corticosteroid may resolve SDB symptoms in almost one-half of children and could be a viable option for primary care.  This study provides promising results for the treatment of SDB in children.

The findings could have important implications for the management of SDB in the future and could lead to improved quality of life for children with SDB. Further research is needed to determine the long-term effects of intranasal steroids and saline on SDB in children, and to identify other treatments that could help to improve symptoms and quality of life.
JAMA, Jan-17-23

Share this article with a friend:

Get emailed clinical trial results in the categories of your choice:
Free subscription to clinical trial results

20,000 clinical trials are seeking participants.
Signup and be matched to trials near you
This free service will notify you of current and future clinical trial matches.

This content is for informational and educational purposes only. It is not intended to provide medical advice or to take the place of such advice or treatment from a personal physician. All readers/viewers of this content are advised to consult their doctors or qualified health professionals regarding specific health questions. CenTrial Data Ltd. does not take responsibility for possible health consequences of any person or persons reading or following the information in this educational content. Treatments and clinical trials mentioned may not be appropriate or available for all trial participants. Outcomes from treatments and clinical trials may vary from person to person. Consult with your doctor as to whether a clinical trial is a suitable option for your condition. Assistance from generative AI tools may have been used in writing this article.